Immunovant (IMVT) Times Interest Earned (2019)

Immunovant (IMVT) has 8 years of Times Interest Earned data on file, last reported at $0.52 in Q1 2026.

• Quarterly Times Interest Earned changed 0.16% year-over-year to $0.52 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.15 (down 92.66% YoY) and the FY2026 annual result came in at -$0.62, up 30.15% from the prior year.
• Times Interest Earned rose to $0.52 in Q1 2026, from $0.07 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $0.88 in Q4 2023 to a low of -$3077.5 in Q2 2022.
• A 5-year average of -$195.85 and a median of $0.38 in 2024 frame the typical range for Times Interest Earned.
• Annual changes were most pronounced in 2022 — Times Interest Earned plunged 111913.04% — and 2023, when it soared 104.36%.
• Tracing IMVT's Times Interest Earned over 5 years: stood at $0.45 in 2022, then surged by 94.9% to $0.88 in 2023, then tumbled by 56.85% to $0.38 in 2024, then sank by 81.75% to $0.07 in 2025, then jumped by 646.21% to $0.52 in 2026.
• The last three Times Interest Earned figures came in at $0.52 (Q1 2026), $0.07 (Q4 2025), and -$1.62 (Q3 2025), per Business Quant data.